Figure 2 | Hypertension Research

Figure 2

From: Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients

Figure 2

Changes in the UA level in patients whose baseline levels were the median value of ≥5.8 mg dl−1 (Upper Group, n=20) compared with those in whom they were <5.8 mg dl−1 (Lower Group, n=20). The UA level in the Upper Group decreased significantly during irbesartan treatment (from 7.0±0.9 to 6.4±1.4 mg dl−1, P=0.017), whereas that in the Lower Group did not do so (4.6±1.0 vs. 4.7±0.9 mg dl−1, P=0.641). UA, uric acid.

Back to article page